Articles Tagged With:
-
AOHP issues new respiratory position statement stressing competence, training
The Association of Occupational Health Professionals in Healthcare recently adopted a new position statement emphasizing that respiratory protection is a “critical area of competence” for OHPs in healthcare.
-
Following last year’s misfire, EH programs may get more pushback, questions about flu shots
Employee health professionals with voluntary seasonal influenza vaccination can expect a tougher sell this year to skeptical healthcare workers, many of whom will recall last year’s mismatched batch that whiffed on a widely circulating H3N2 strain that had antigenically drifted.
-
Efficacy questioned, but consider pertussis revaccination of HCWs during outbreak
If there is an increased risk of pertussis in a healthcare setting evidenced by documented or suspected healthcare-associated transmission of pertussis, employee health professionals can consider revaccination of healthcare personnel with Tdap vaccine, the CDC recommends.
-
One case of measles leads to more than 1,000 exposures to HCWs and patients
There are maddening, laborious measles exposure incidents in hospitals, and then there is the epic disaster that unfolded in May 2014 at Inova Health System in Fairfax, VA.
-
Take-home points in the ANA’s vaccination mandate
The American Nurses Association issued a new position statement on healthcare vaccinations on July 21, 2015.
-
Nursing Leaders: Mandate Recommended Shots
This could be a turning point in the controversy over healthcare immunizations.
-
Compliance Mentor - September 2015
-
ED Push - September 2015 Second Issue
-
FDA Actions
In this section: Drug to treat hypoactive sexual desire disorder in premenopausal women goes live; new drug available to prevent delayed phase chemotherapy-induced nausea and vomiting; DPP-4 inhibitors used to treat type 2 diabetes may cause severe and disabling joint pain; and evolocumab receives approval.
-
Aspirin and NSAIDs Reduce Colorectal Cancer Risk
Long-term continuous use of low-dose aspirin and long-term use of non-aspirin nonsteroidal anti-inflammatories was associated with reduced colorectal cancer risk.